Penumbra receives FDA clearance for Lightning technology to treat deep vein thrombosis
October 21, 2026
Clearance is supported by BOLT-DVT findings on clot removal, safety and patient outcomes
Clearance is supported by BOLT-DVT findings on clot removal, safety and patient outcomes
Edwards Lifesciences (NYSE: EW) obtained FDA approval for its minimally invasive procedure to help repair a leaky tricuspid heart valve.